These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21140373)

  • 21. Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma.
    Martínez A; Sanchez-Salorio M
    Acta Ophthalmol; 2010 Aug; 88(5):541-52. PubMed ID: 19799592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study.
    Newman-Casey PA; Niziol LM; Gillespie BW; Janz NK; Lichter PR; Musch DC
    Ophthalmology; 2020 Apr; 127(4):477-483. PubMed ID: 31932093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in visual function after intraocular pressure reduction using antiglaucoma medications.
    Prata TS; Piassi MV; Melo LA
    Eye (Lond); 2009 May; 23(5):1081-5. PubMed ID: 18670465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
    Chiselită D;
    Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
    Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of evening and morning dosing of travoprost 0.004%/timolol 0.5% fixed combination in 6 month period.
    Suić SP; Laus KN; Dosen VM; Ekert M; Mandić Z; Bojić L
    Coll Antropol; 2010 Sep; 34(3):847-52. PubMed ID: 20977071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.
    Martinez-de-la-Casa JM; Castillo A; Garcia-Feijoo J; Mendez-Hernandez C; Fernandez-Vidal A; Garcia-Sanchez J
    Curr Med Res Opin; 2004 Sep; 20(9):1333-9. PubMed ID: 15383180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension.
    Suzuki ER; Franklin LM; da Silva LJ; Figueiredo CR; Netto JA; Batista WD
    Curr Med Res Opin; 2006 Sep; 22(9):1799-805. PubMed ID: 16968583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
    Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
    J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.
    Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MV; Mallick S;
    Clin Ther; 2006 Nov; 28(11):1803-11. PubMed ID: 17213000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.
    Scherzer ML; Liehneova I; Negrete FJ; Schnober D
    Adv Ther; 2011 Aug; 28(8):661-70. PubMed ID: 21773673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term relationship between intraocular pressure and visual field loss in primary open-angle glaucoma.
    Inatani M; Iwao K; Inoue T; Awai M; Muto T; Koga T; Ogata-Iwao M; Hara R; Futa R; Tanihara H
    J Glaucoma; 2008; 17(4):275-9. PubMed ID: 18552612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
    Pajic B; Pajic-Eggspuehler B; Häfliger IO
    Curr Med Res Opin; 2010 Sep; 26(9):2213-9. PubMed ID: 20673200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, placebo-controlled clinical trial: design and methodology.
    Garway-Heath DF; Lascaratos G; Bunce C; Crabb DP; Russell RA; Shah A;
    Ophthalmology; 2013 Jan; 120(1):68-76. PubMed ID: 22986112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.
    Denis P; Andrew R; Wells D; Friren B
    Eur J Ophthalmol; 2006; 16(3):407-15. PubMed ID: 16761242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
    Facio AC; Reis AS; Vidal KS; de Moraes CG; Suzuki R; Hatanaka M; Susanna R
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):447-51. PubMed ID: 19860553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between visual field severity and response to fixed combination dorzolamide/timolol or timolol alone.
    Olander KW; Galet VA; Jia G; Smugar SS; Stewart WC
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):357-64. PubMed ID: 19441888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up period.
    Mandić Z; Novak-Laus K; Bojić L; Popović-Suić S; Ekert M; Dosen VM; Pelcić G; Clementi D; Dobutović D; Biuk D; Iveković R; Kovacić Z; Pavan J; Susić N; Geser MZ; Krolo I; Barisić F; Jurić-Miletić A; Dogan KK; Tomić M; Kovacević S
    Acta Clin Croat; 2010 Dec; 49(4):411-9. PubMed ID: 21830452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.